Daud, Shaira I.

HRN: 28-21-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
CEFUROXIME 750MG (VIAL)
12/06/2025
12/13/2025
IV
630mg
Q8hours
PCAP-B
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: